Ataxia-telangiectasia (A-T) is an autosomal recessive disorder involvi
ng cerebellar degeneration, immunodeficiency, chromosomal instability,
radiosensitivity and cancer predisposition. The responsible gene, AIM
, was recently identified by positional cloning and found to encode a
putative 350 kDa protein with a PI 3-kinase-like domain, presumably in
volved in mediating cell cycle arrest in response to radiation-induced
DNA damage. The nature and location of A-T mutations should provide i
nsight into the function of the ATM protein and the molecular basis of
this pleiotropic disease. Of 44 A-T mutations identified by us to dat
e, 39 (89%) are expected to inactivate the ATM protein by truncating i
t, by abolishing correct initiation or termination of translation, or
by deleting large segments. Additional mutations are four smaller in-f
rame deletions and insertions, and one substitution of a highly conser
ved amino acid at the PI 3-kinase domain. The emerging profile of muta
tions causing A-T is thus dominated by those expected to completely in
activate the AIM protein. ATM mutations with milder effects may result
in phenotypes related, but not identical, to A-T.